News

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...
Cervical cancer diagnosis house Truscreen (ASX:TRU) says it should achieve cash flow break even by March next year.
A five-year-old boy from Kidderminster with a rare condition has received the "surprise of a lifetime" at his favourite football club.
This speculative ASX stock could be destined to almost double in value according to analysts at Bell Potter. Let's see ...
Since the dawn of human spaceflight, scientists have carefully studied the effects of space and microgravity on astronauts.
Amylyx Pharmaceuticals has discontinued the clinical development program for AMX0035, for the treatment of progressive supranuclear palsy.
Neurodegeneration in multiple sclerosis can be monitored via OCT of inner retinal layers in the macular region, according to ...
Dr Ray O’Connor takes a look at the latest articles on opthalmology, including the association between long-term exposure to ...
Gamified exercise training improves hippocampal volume and cognitive performance in mild neurocognitive disorders, offering ...
Ocular Therapeutix, Inc. ( NASDAQ: OCUL) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Well, welcome Pravin. Great to have you here.
Avoiding and managing ocular radiotoxicity are increasingly important as more patients undergo radiotherapy for HNC, esp.
A new study explores the "drusen ooze" hypothesis, revealing how drusen can regress without atrophy in age-related macular ...